A detailed history of First United Bank & Trust transactions in Neogenomics Inc stock. As of the latest transaction made, First United Bank & Trust holds 26,000 shares of NEO stock, worth $459,940. This represents 0.14% of its overall portfolio holdings.

Number of Shares
26,000
Previous 26,000 -0.0%
Holding current value
$459,940
Previous $360,000 6.39%
% of portfolio
0.14%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 20, 2021

SELL
$41.56 - $59.88 $41,560 - $59,880
-1,000 Reduced 3.7%
26,000 $1.25 Million
Q3 2020

Oct 13, 2020

SELL
$33.26 - $40.48 $99,780 - $121,439
-3,000 Reduced 10.0%
27,000 $996,000
Q2 2019

Jul 09, 2019

SELL
$19.57 - $24.1 $78,280 - $96,400
-4,000 Reduced 11.76%
30,000 $658,000
Q2 2018

Jul 12, 2018

SELL
$7.99 - $14.05 $39,950 - $70,250
-5,000 Reduced 12.82%
34,000 $446,000
Q3 2017

Oct 17, 2017

BUY
$9.11 - $11.26 $355,290 - $439,140
39,000
39,000 $434,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.23B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track First United Bank & Trust Portfolio

Follow First United Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First United Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First United Bank & Trust with notifications on news.